Ventripoint Diagnostics Ltd. announced it has appointed Justin Leushner as CEO of the company. Dr. George Adams has resigned as CEO and has been elected as Chairman of the Board of Directors of the company. Mr. Leushner's appointment is a reflection of the Company's current state: ready for commercial success.

Ventripoint is poised for major growth and Justin's unique leadership experience in life sciences and biotechnology will help ensure the Company's future success. There is enormous opportunity for Ventripoint and all at the Company look forward to having Mr. Leushner at the helm. Mr. Leushner has also been appointed a Director of the Company and Mr. Danny Dalla-Longa has stepped down as a Director.